Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Lenrispodun in systolic heart failure
NCT03387215Phase 2Completed
- Sponsor
- Intra-Cellular Therapies
- Start
- Jul 2018
- Primary completion
- Mar 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of lenrispodun, sponsored by Intra-Cellular Therapies. Started Jul 2018; status: completed.
02
Drugs
lenrispodun
Beyond the preview
Go deeper on NCT03387215.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03387215.